FEATURES OF THE VIRAL HEPATITIS C COURSE IN HIV-INFECTED PERSONS AND THEIR TREATMENT

Authors

  • V. D. Moskaliuk Bukovyna State Medical University
  • I. V. Rudan Bukovyna State Medical University

DOI:

https://doi.org/10.11603/1681-2727.2018.4.9776

Keywords:

HCV infection, HIV infection, combined infection, peculiarities of the course, treatment

Abstract

The aim of the study – based on the analysis of literary information to highlight the features of the course of viral hepatitis C in HIV-infected persons, as well as the basic principles of treatment of such patients and used drugs in the world and in Ukraine.

HIV and parenteral viral hepatitis refer to socially important diseases that can significantly affect the demographic situation in the country. Except the common ways and factors of transmission of viruses, the involvement of adolescents and young people to the epidemic process is the dominant factor that complicates the epidemiological situation with regard to HIV infection and parenteral viral hepatitis in Ukraine. The age factor is due to the phenomena of the current epidemic of drug addiction.

From the published data of a number of studies, the mutual influence of HIV and chronic viral hepatitis C on the course of both HIV-infection and chronic hepatitis C (CHC) is known. The incidence of AIDS and AIDS-related deaths is significantly higher in people with combined HCV / HIV infection, which is now a global public health problem.

The basic principles of treating patients with HCV in HIV-infected patients are consistent with those not infected with HIV. For the treatment of HCV-infection, current AASLD guidelines do not recommend interferon-based schemes anymore. Instead, nowadays the first-line treatment is considered to be oral antiviral agents of direct action. At the same time, interferon-containing treatment regimens are still used in Ukraine.

According to published results of a number of studies, the terminal stage of liver disease is a common cause of hospitalization and death of patients with combined HCV / HIV infection. But there are still controversial therapies for people with combined HIV and parenteral viral hepatitis. Therefore, the choice of optimal tactics for the management of such patients and the timely appointment of adequate treatment remains relevant.

Author Biographies

V. D. Moskaliuk, Bukovyna State Medical University

Doctor of Medicine, Professor of the Internal Medicine and Infectious Diseases Department of Bukovyna State Mediсal University

I. V. Rudan, Bukovyna State Medical University

assistant of the Internal Medicine and Infectious Diseases of Bukovyna State Mediсal University

Published

2019-01-30

How to Cite

Moskaliuk, V. D., & Rudan, I. V. (2019). FEATURES OF THE VIRAL HEPATITIS C COURSE IN HIV-INFECTED PERSONS AND THEIR TREATMENT. Infectious Diseases – Infektsiyni Khvoroby, (4), 56–64. https://doi.org/10.11603/1681-2727.2018.4.9776

Issue

Section

Reviews and lectures